510(k) Report

510(k) · Cleared

Recalled · 2009

Horizon Phacoemulsification System, Model HZN-2030

K020527510(k) TraditionalCleared Jul 9, 2002140-day reviewClass II21 CFR 886.4670Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

American Optisurgical, Inc. · HQC Unit, Phacofragmentation

Cleared on Jul 9, 2002 as substantially equivalent to K931354 (American Optical Corp., 1994) and 2 other predicates after a 140-day review. Its family tree reaches back 1 generation to 1994. 1 later device descends from it. It has been recalled once.

Decided
Jul 9, 2002
Review
140 days
Class
Class II
Product code
HQC
Recalls
1
Predicates
3

Its longest line of descent runs back 1 generation to K931354 (1994). 3 ancestors in all. 1 later device descends from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 1999: 1 other ancestor1995: 1 other ancestor2008: 1 descendant clearedK931354 · P4000 Phacoemulsifier · American Optical Corp. · 19941990200020102020
Other ancestors, by generationDescendants, by generation 1 generation back: 2 other ancestors 1 generation forward: 1 descendant K931354 · P4000 Phacoemulsifier · American Optical Corp. · 19940
  1. Root · 1 generation backK931354 P4000 PhacoemulsifierAmerican Optical Corp. · 1994
  2. This deviceK020527 Horizon Phacoemulsification System, Model HZN-2030American Optisurgical, Inc. · 2002
  3. Descendant · cites it directly · 0 of its ownK080803 Visual Phacoemulsification System, Model 551American Optisurgical, Inc. · 2008

Most influential descendants

Showing 1 of 1 · See all
  • K080803Visual Phacoemulsification System, Model 551American Optisurgical, Inc. · 2008 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K931354P4000 PhacoemulsifierAmerican Optical Corp.1994—
0 (this device)K020527Horizon Phacoemulsification System, Model HZN-2030American Optisurgical, Inc.2002—
+1K080803Visual Phacoemulsification System, Model 551American Optisurgical, Inc.2008—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199510
199910

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200810
FIG. 1 — Lineage of K020527, 1994–2008Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in HQC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new HQC device

  1. #1 K261264 Stellaris Elite™ vision enhancement system…score 13.4 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K931354P4000 Phacoemulsifier
Summary page 1
…ation Name: As per 2 1 CFR 886.4670, the product nomenclature is Phacofiagmentation System. Predicate P4000 Phacoemulsifier System (K93 1354) Devices Ocusystern Art Advantage (K.991852) OMS Diplomax Phacoemulsifier (K946054)…
American Optical Corp.1994—
*K991852Ocusystem Art Advantage, Model 995
Summary page 1
…Phacofiagmentation System. Predicate P4000 Phacoemulsifier System (K93 1354) Devices Ocusystern Art Advantage (K.991852) OMS Diplomax Phacoemulsifier (K946054) Intended Use The Horizon Phacoemulsification System p…
Surgical Design Corp.1999—
*K946054Diplomax
Summary page 1
…P4000 Phacoemulsifier System (K93 1354) Devices Ocusystern Art Advantage (K.991852) OMS Diplomax Phacoemulsifier (K946054) Intended Use The Horizon Phacoemulsification System performs phacofragrnentatiod phacoemulsi…
Optical Micro Systems, Inc.1995—

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K080803Visual Phacoemulsification System, Model 551American Optisurgical, Inc.20080

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Mar 24, 2009Not classifiedZ-1808-2009Software change controlDevice operation interrupted: A software bug causes Phaco to stop when vacuum goes above 300 mmHg while in Multi Burst mode. Use of this product at the parameters specified above could lead to a delay in surgery that might present a…

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • None of the 3 ancestors has a recall.
  • Of its descendants, K080803 (American Optisurgical, Inc., 2008) has gone furthest, with 0 descendants of its own.

How does its category compare?

All HQC devices

HQC Unit, Phacofragmentation: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · HQC

3in 2025

2008: 42009: 52010: 32011: 52012: 52014: 42015: 32016: 12017: 32019: 42020: 42021: 12022: 42023: 12024: 52025: 32026 (partial year): 3
2007high 5 (2009) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · HQC

267in 2025

2008: 162 days median2009: 131 days median2010: 142 days median2011: 129 days median2012: 125 days median2014: 135 days median2015: 124 days median2017: 214 days median2019: 126 days median2020: 227 days median2022: 245 days median2024: 197 days median2025: 267 days median2026 (partial year): 115 days median
2007high 267 (2025) · low 124 (2015)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · HQC

1in 2025

2008: 12009: 12010: 222011: 42012: 12014: 12018: 22022: 52023: 12025: 1
2007high 22 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · HQC

1,799in 2025

2007: 3412008: 4442009: 5402010: 2,4312011: 1,8022012: 2,2772013: 2,7722014: 2,7402015: 3,3552016: 3,3742017: 2,7812018: 2,4162019: 2,2872020: 1,2172021: 1,6732022: 1,9072023: 1,7992024: 2,1202025: 1,799
2007high 3,374 (2016) · low 341 (2007)2025

MAUDE reports naming product code HQC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—0341
200841621444
200951311540
20103142222,431
2011512941,802
2012512512,277
20130—02,772
2014413512,740
2015312403,355
20161—03,374
2017321402,781
20180—22,416
2019412602,287
2020422701,217
20211—01,673
2022424551,907
20231—11,799
2024519702,120
2025326711,799
202631150—

What is it indicated for?

The Horizon Phacoemulsification System performs

phacofragmentation/ phacoemulsification with ultrasonic energy to disrupt

and extract cataractous lens material from the eye.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K020527: Horizon Phacoemulsification System, Model HZN-2030.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K020527

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026